Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Chen

Showing results (301-310 of 311) with videos related to

Pageof 32
Sort By:
Cell Host & Microbe|February 26, 2019
Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in MiceAshira Lubkin, Warren L Lee, Francis Alonzo, et al.
American Heart Journal|October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shockMarc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
JAMA Network Open|February 22, 2023
Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive RadiotherapyAlexander Rühle, Sebastian Marschner, Marlen Haderlein, et al.
Nature Communications|June 24, 2022
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficienciesJohn Hilton, Karen Gelmon, Philippe L Bedard, et al.
JAMA|December 19, 2018
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysisJason W Busse, Li Wang, Mostafa Kamaleldin, et al.
European Radiology|August 28, 2025
Musculoskeletal infection reporting and data system (MSKI-RADS): multi-institutional wider generalizability studyAvneesh Chhabra, Angela He, Majid Chalian, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive ChemoradiationAlexander Rühle, Maria Weymann, Max Behrens, et al.
The Journal of Biological Chemistry|March 3, 2018
LysMD3 is a type II membrane protein without an <b></b> role in the response to a range of pathogensChristine C Yokoyama, Megan T Baldridge, Daisy W Leung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2024
Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomesAlexander Rühle, Maria Weymann, Max Behrens, et al.
AEM Education and Training|June 18, 2021
The revised Approved Instructional Resources score: An improved quality evaluation tool for online educational resourcesAndrew Grock, Jaime Jordan, Fareen Zaver, et al.
Pageof 32

Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Cell Host & Microbe|February 26, 2019
Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in MiceAshira Lubkin, Warren L Lee, Francis Alonzo, et al.
American Heart Journal|October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shockMarc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
JAMA Network Open|February 22, 2023
Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive RadiotherapyAlexander Rühle, Sebastian Marschner, Marlen Haderlein, et al.
Nature Communications|June 24, 2022
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficienciesJohn Hilton, Karen Gelmon, Philippe L Bedard, et al.
JAMA|December 19, 2018
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysisJason W Busse, Li Wang, Mostafa Kamaleldin, et al.
European Radiology|August 28, 2025
Musculoskeletal infection reporting and data system (MSKI-RADS): multi-institutional wider generalizability studyAvneesh Chhabra, Angela He, Majid Chalian, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive ChemoradiationAlexander Rühle, Maria Weymann, Max Behrens, et al.
The Journal of Biological Chemistry|March 3, 2018
LysMD3 is a type II membrane protein without an <b></b> role in the response to a range of pathogensChristine C Yokoyama, Megan T Baldridge, Daisy W Leung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2024
Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomesAlexander Rühle, Maria Weymann, Max Behrens, et al.
AEM Education and Training|June 18, 2021
The revised Approved Instructional Resources score: An improved quality evaluation tool for online educational resourcesAndrew Grock, Jaime Jordan, Fareen Zaver, et al.
Pageof 32